Library

ASCO KCA Europe lectures:

>3039_Kollmannsberger_MGCD265-a-multitargeted-oral-tyrosine-kinase-receptor-inhibitor-of-Met-and-VEGFR_Dose-escalation-phase-I-study.jpg<Download

ASCO 2012 Europe from Birdie AKCK

                  >ASCO_Meeting12_Presented-Genitourinary-Cancer_RCC.pdf<Download

                  >ASCO_2012_Posters_and_Abstracts_1.zip<Invalid download ID.

                  >ASCO_2012_Posters_and_Abstracts_2.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_3.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_4.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_5.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_6.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_7.zip<Download

                  >ASCO_2012_Posters_and_Abstracts_8.zip<Download

>ASCO-Europe-2012-O-Brian.zip<Download

>DrMcDermott-ASCO-UEUROPE1.doc<Download

>KCA-7th-European-confer.zip<Download

>KCA-Europe-Clark-Nutritional-Status.zip<Download

>KCA-Europe-Powles-Bone-Disease.zip<Download

Biomarker Issues

>A-New-Paradigm-for-Companion-Diagnostics-in-Cancer.pdf<Download

>BAP1-Independent-Marker-of-Outcomes-for-Low-Risk-RCC-_-Cancer-Network.pdf<Download

>biomarkers-for-targeted-th.pdf<Download

>Biomarkers-predict-benefit-of-targeted-therapy-in-metastatic-renal-cell-cancer1.pdf<Download

>bioMrks-of-resp-in-M-RCC-imp-Immunotx.pdf<Download

>Cumulative-no-of-altered-biomarkers-in-mTOR-gene-pathway-in-pts-wit-ccRCC-_-UroToday.pdf<Download

>Markers-in-blood-RCCEichelberg-2009.pdf<Download

>mayo-clinic-RE-SCD-1-Gene-in-RCC.pdf<Download

>MicroRNA-Cluster-Linked-With-Kidney-Cancer-Prognosis.doc<Download

>MUC1-as-prognostic-tool-RCC.pdf<Download

>rcc-molecular-nature1.pdf<Download

>RCC-Tumor-Biomarkers.pdf<Download

>RCC-Biomarkers-Pal-Figlin.pdf<Download

>three-marker-essay-for-mRCC.pdf<Download

>TumorMarkers-General-Cancers_Task_Force_Report.full_.pdf<Download

>Urinary-Biomarkers-for-the-Early-Diagnosis-of-Kidney-Cancer.pdf<Download

Bisphosphonates and RCC

>PracticeUpdate-Bone-Mets-Zometa-.pdf<Download

>Bisphosnonates-RCC-esp.zip<Download

>Bisphosphonates-Jaw-Necrosis.zip<Download

>Bisphosphonates-nonRCC-general-anti-cancer.zip<Download

>emails-notes-re-Bisphosphonates.doc<Download

>genomewide-Pharmacogenetics-of-Bisphosphonate.doc<Download

>kidneycancercare-CAN-bisphosphonates.doc<Download

>Molecular-Mechanisms-of-Action-bisphosphonatesRoelofs-Clin-Cancer-Res-2006.pdf<Download

Immune Therapies General

>AGS-Argos.zip<Download

>Cabozanib.zip<Download

>checkpoint-inhibitors.zip<Download

>Immune-Vaccine-issues.zip<Download

>Other.zip<Download

>PD-1-PD-L1.zip<Download

>Peptides-immunme.zip<Download

>ProLeukin.zip<Download

>RCC-Basics-re-immune-response.zip<Download

>Vaccines-similar.zip<Download

Informedical CME 2010-2011 cont ed RCC

>Informedical CME 2010-2011 cont ed RCC<Download

>2-Subsets-Nathanson.pdf<Download

>3-IL-2-McDermott.pdf<Download

>4-immune-Checkpoint-Sznol.pdf<Download

>5-VEGFinhibit-George.pdf<Download

>6-P13k-Cho.pdf<Download

>7-Targeted-Hutson.pdf<Download

>8-Novel-Chouieri.pdf<Download

>9-Biomarkers-Stadler.pdf<Download

>10-Neoadj-Rathmell.pdf<Download

>11-VEGFresist-Bhatt.pdf<Download

>Overview-Atkins.pdf<Download

Molecular re RCC

>2013_AACR_CPR_FINAL.pdf<Download

>Accurate-Molecu-Class-of-Renal-tumor-MicroRNA-expr.pdf<Download

>Accurate-Molecu-Class-of-Renal-tumor-MicroRNA-expr1.pdf<Download

>BAP1-loss-defines-a-new-class-of-renal-Cell-Carcinoma.pdf<Download

>Cancer-Genomics-_-ACKC.pdf<Download

>ChimericAntigenReceptorTech_Executive_Summary_Icarus-FINAL.pdf<Download

>Chromosone-3p-heterozygosity-is-associated-with-unique-metabolic-network-in-RCC.2014-Gatto-1319196111.pdf<Download

>ClearCode-34-PrognasticRiskPreditor-for-localized-RCC-Rathmell.doc<Download

>ClearCode34_-A-Prognostic-Risk-Predictor-for-Localized-Clear-Cell-Renal-Cell-Carcinoma.pdf<Download

>Comprehensive-molecular-characterization-of-clear-cell-renal-cell-carcinoma-_-Nature-_-Nature-Publishing-Group.pdf<Download

>Diagnostic-and-prognostic-potential-of-differentially-expressed-miRNAs-between-metastatic-and-non-metastatic-RCC-at-the-time-of-nephrectomy-RC_-UroToday.pdf<Download

>Direct-to-consumer-Genetic-Testing-from-ASCO.doc<Download

>Effects-on-survival-of-BAP1-and-PBRM1-mutations-in-sporadic-clear-cell-renal-cell-carcinoma_-a-retrospective-analysis-with-independent-validation-_-The-Lancet-Oncology.pdf<Download

>Emerging-molecular-class-in-RCC-Implication-drug-dev.pdf<Download

>Epigenetics-of-RCC-Path-towards-new-dx-tx.pdf<Download

>Epigenetics-of-renal-cell-carcinoma.doc<Download

>functional-genomics-identifies-novel-genes-essential-for-ccRCC-tumor-.pdf<Download

>Gene-express-profile-predi-survival-in-cRCC.pdf<Download

>Genetic-Basis-for-RCC-Linehannihms223791.pdf<Download

>Genetic-Basis-of-Kidney-Cancer-Linehannihms223791.pdf<Download

>Genomic-data-mining-firm-hopes-to-help-personalized-medicine-become-commonplace-in-3-5-years.pdf<Download

>Genomic-Testing_-New-Frontier-in-Cancer-Therapy-_-PracticeUpdate.pdf<Download

>In-Cancer-Treatment-New-DNA-Tools-NYTimes.pdf<Download

>Innovations-Challenges-RCC.pdf<Download

>Intratumor-Heterogeneity-and-Branched-Evolution-Gerlinger-NEJM.pdf<Download

>Is-the-Cure-for-Cancer-Inside-You_-NYTimes.pdf<Download

>Lack-of-KRAS-BRAF-Mutation-in-RCC.pdf<Download

>Management-of-RCC_-What-Can-Molecular-Pathology-Contribute_-printer-friendly.pdf<Download

>medintel_v9n1-RCC-2011-BPRM1-gene1.pdf<Download

>Meta-analysis-of-Clear-Cell-Renal-Cell-Carcinoma-Gene-Expression-Defines-a-Variant-Subgroup-and-Identifies-Gender-Influences-on-Tumor-Biology-_img-src.pdf<Download

>Mol-Cancer-Res-2012-Jonasch-859-80-inc-ccRCCa-ccRCCb.pdf<Download

>Molecu-biomarked-in-adv-RCCClin-Cancer-Res-2014-Maroto.pdf<Download

>Molecular-Stratif-of-ccRCC-distin-subtypes-survival-patterns.pdf<Download

>Molecular-Sub-class-of-Renal-epith-Tumr-using-meta-analy-of-gene-expr-microarrays.pdf<Download

>molecular-subsets-ch-6-http___www.informedicalcme.pdf<Download

>Mutational-hetergeneity-in-Cancer-Genesnihms-471461.pdf<Download

>NCCN-Molecular-testingEffective-Effici-and-ReimbS-1.full_.pdf<Download

>NF-_B-inhibition-by-bortezomib-permits-IFN-_…pdf<Download

>NGS-issues-31333_print.pdf<Download

>Oxidants-antioxidants-and-the-current-incurability-of-metastic-cancersOpen-Biol.-2013-Watson-.pdf<Download

>Pathway-Signature-and-Cellular-Differenetiation-in-ccRCC.pdf<Download

>PracticeUpdate-speaks-with-DrJonasch-sequencing.doc<Download

>Re-Defining-Early-Onset-Kidney-Cancer-implications-for-Germline-Somatic-Mutations-testing.doc<Download

>Renal-cell-carcinoma_-a-step-closer-to-a-new-classification-_-The-Lancet-Oncology.pdf<Download

>single-cell-exome-seq-reveal-since-nucleotime-RCC.pdf<Download

>Src-RCC.pdf<Download

>Steroid_receptors_in_renal_cell_carcinoma.pdf<Download

>Table-121-gene-list-to-get-34-gene-ccRCC.doc<Download

>The-emerging-role-of-nuclear-factor-…pdf<Download

>Therapeutic-Advances-re-Molecular-RINI-2012-with-images.full_.pdf<Download

>what-can-molec-path-contribut-RCC-CME-2011.doc<Download

 Partial Nephrectomy & related

>Low-metastic-rate-local-nephron-sparing-surgery.pdf<Download

 Pathology issues genes scan info re type

>4635_Schutz_Genetic-polymorphisms-influence-in-outcome-of-mRCC-pts-treated-with-VEGF-targeted-agents.pdf<Download

>A-SUMOylation-defective-MITF-germline-mutation-predis…pdf<Download

>Bill-Gates-helps-genomic-tests-startup-lay-firm-foundation-FierceBiomarkers.pdf<Download

>Cancer-Geek-and-Twitter.doc<Download

>Cancer-scans-my-give-false-picture-of-genes-multiple-mutations.doc<Download

>Clear-cell-papillary-RCC-ccpRCC.pdf<Download

>diag-path-cynchronous-ccrcc-and-tcrcc-genetic-evi-1746-1596-7-21.pdf<Download

>differe-Diagnosis-or-Renal-tumor-Clear-cytoplasm.pdf<Download

>DNA-analysis-Susan-Poteat.doc<Download

>epigenetics_primer.pdf<Download

>Epigentics-of-RCC-.pdf<Download

>International-mRCC-Database-Consortium-Seeks-to-Inform-Prognosis-Prediction-_-Genitourinary-Cancers-Symposium.pdf<Download

>Mayo-Clinic-Mayo-Clinic-Researchers-Find-Genetic-Secrets-to-Common-Kidney-Cancer.pdf<Download

>Mislabeled-cell-lines.doc<Download

>Novel-Heritable-Melanoma-and-Renal-Cancer-Factor-Identified-Cancer-Network.pdf<Download

Pathology RCC subtypes

>vHL-loss-subtypes-of-RCC.doc<Download

>www.pathology-characteristics-chart.pdf<Download

>www.pathology-Fig-1-ccRCC.pdf<Download

>www.pathology-fig-2-Pap-type1.pdf<Download

>www.pathology-fig-3-chromophobe.pdf<Download

>www.pathology-fig-4-ccPap-RCC.pdf<Download

>www.pathology-fig-5-TFE-3-.pdf<Download

>www.pathology-fig-6-other-subtype.pdf<Download

>Pathology-Reports-National-Cancer-Institute.pdf<Download

>Primary-renal-lymphoma-mimicking-renal-cell-carcinoma.pdf<Download

>Proteomic-Research-Unfurls-Cancer-Conundrum-Datanami.pdf<Download

>The-Oncologist-adv-in-Genetics-of-familial-RCc532.full_.pdf<Download

>Trio-of-biomarkers-may-help-identify-kidney-cancer-in-early-stages-_-Renal-Cancer-_-UroToday.pdf<Download

>Tumor-Biol-prog-fctrs-in-RCC-Pantuch-BelldeThe-Oncologist-2011-Finley-4-13.pdf<Download

>Tumor-Evolution-More-Complex-than-Imagined-By-Charles-Bankhead.doc<Download

>Tumor-Heterogenity-may-folster-tumor-evolution-and-hinder.doc<Download

 Radiation Ablation

>Adjuvant-Radiotherapy-May-Benefit-High-Risk-RCC-Patients-Renal-and-Urology-News.pdf<Download

>brain-mets-and-SRS-etc-Amer-Cancer.pdf<Download

>CombiningRadiationAndChemo.pdf<Download

>New-and-Emerging-Therapies-for-Bone-Metastases-in-Genitourinary-Cancers.pdf<Download

>Pancreatic-Metastases-From-RCC-Treated-With-SBRT.doc<Download

>Radiofrequency-ablation-of-renal-tumours-with-clinical.doc<Download

>Radiolo-CT-arterial-vs-venous-phase-RCC.pdf<Download

Rare subtypes

>Ann-Oncol-2013-Bellmunt-1730-40.pdf<Download

>CDI2012-473245.pdf<Download

>Chromophobe.zip<Download

>Collecting-Duct-HLRCC.doc<Download

>Durable-Remission-of-Metastatic-RCC-c-Gemcit-CapeciAfter-Failure-of-TT.pdf<Download

>Hereditary-General.zip<Download

>Papillary.zip<Download

>Pathology-vis-IHC-cc-vs-non-cc-h.doc<Download

>Phase-II-Study-of-Gemcitabine-Carboplatin-and-Bevacizumab-in-Pts-w-Adv-Unresectable-or-mUrothelial-Cancer.pdf<Download

>Sarcomatoid.zip<Download

>SDHB-Mutations.zip<Download

>Targeted-therapies-and-the-treatment-of-non-clear-cell-renal-cell-carcinoma.pdf<Download

>TT-and-non-ccRCC-Bellmunt.pdf<Download

>WJSO-_-Full-text-_-Metastatic-collecting-duct-carcinoma-of-the-kidney-treated-with-Sunitinib.pdf<Download

>Xp-11.2-Translocational.zip<Download

RCC General Overviews Recent

>CCO_GU_2012_QUINN-RCC-only_Slides.ppt<Download

>CCO_RCC_ExpertMOTZER_Insight_Slides.ppt<Download

>EAU-Calling-for-Treatment-of-All-Renal-Cell-Carcinomas.pdf<Download

>kidney-cancer-journal-20121.pdf<Download

>mRCC-Adv-Future-Atkins.pdf<Download

>mRCCEvidence-experience.doc<Download

>New-Insights-into-the-management-of-RCC.pdf<Download

>Normalizing-Tumor-Micro-EnvironJCO-2013-Jain-2205-18.pdf<Download

>Novel-Agents-in-RCC-A-reality-check-Rini-2012.pdf<Download

>Quinn-re-RCCGU_2012_CR_CME.pptm<Download

>RCC-Basics.zip<Download

>RCC-Chouieri-re-NCCN-Guidelines-lecture-slides.pdf<Download

>Recent-developments-in-the-treatment-of-renal-cell-carcinoma.pdf<Download

>What-is-the-optimal-therapy-for-patients-with-metastatic-renal-cell-carcinoma-who-progress-on-an-initial-VEGFr-TKI.pdf<Download

RCC Guidelines Mixed

>kidney-cancer-NCCN-Guidelines.pdf<Download

>Metastatic-Potential-in-RCC-less-than-7cm-Swedish-study.pdf<Download

>Newly-diagnosed-with-a-kidney-tumor-is-frightening-to-say-the-least.doc<Download

>PFS-May-Be-Valid-Surrogate-Endpoint-for-Overall-Survival-in-Metastatic-RCC.doc<Download

>RECISTGuidelines.pdf<Download

>Robin-Martinez-re-staging-and-explanation1.doc<Download

>Stage-Cellular-Classification-of-Renal-Cell-Cancer.doc<Download

 Surgery Issues in SM Ren Mass

>2010_Staehler_Liver-resection-for-metastatic-disease-prolongs-survival-in-mRCC.pdf<Download

>AUA-2013-Session-Highlights_-AUA-Guideline-Presentation_-Follow-up-care-for-renal-cancer-_-AUA-2013-Renal-Cancer-_-AUA-2013-_-Conferences.pdf<Download

>Cancer_Network_-_The_Evolving_Role_of_Cytoreductive_Surgery_for_Metastatic_RCC-_2014-03-17.pdf<Download

>Cytoreductive-nephrectomy.doc<Download

>Integration-of-surgery-system-therapy-adv-and-mRCC.pdf<Download

>IVC-Thromubs-surgery-ASCO-.doc<Download

>Metastatic-Potential-in-Renal-Cell-Carcinomas-x022647_hsp-sp.pdf<Download

>mRCC-with-without-NephrectomyAnn-Oncol-2010-Richey.pdf<Download

>Nephrectomy-INF-compared-with-INF-alone-2001.pdf<Download

>Preoperatively-Misclassified-Renal-Masses.doc<Download

>prognostic-Stratifcation-of-RCC-us-patholog-tri-micro-Vascul.doc<Download

>Renal-Cell-Carcinoma-What-the-Surgeon-and-Treating-Physician-Need-to-Know.pdf<Download

>Single-nucleotide-polymorphisms-and-risk-of-recurrence-of-RCC-re-MET-rs177…-_-The-Lancet-Oncology.pdf<Download

>Small-Renal-Masses-Monitor-Issues.zip<Download

>Survival-after-complete-surgical-resection-of-multipl…pdf<Download

>The-role-of-metastasectomy-in-rcc-era-of-TT-Abstract-_-Renal-Cancer-_-UroToday.pdf<Download

>The-value-of-cytoreductive-nephrectomy-for-metastatic-renal-cell-carcinoma-in-the-era-of-targeted-therapy.pdf<Download

>Tumor-burden-and-PFS-OS.doc<Download

>Tumor-size-does-not-predict-risk-of-metastatic-disease-or-prognosis-of-small-renal-cell-carcinomas.doc<Download

 Targeted Therapies mixed

>A-validated-tumorgraft-model-activity-dovitinib-t-rRCC-_Beyond-the-Abstract_-Brugarolas-Renal-Cancer-_-UroToday.pdf<Download

>AntVEGF-meds-can-be-stopped-RINIi.doc<Download

>Bevacizumab-_-the-Story-is-Not-So-Simple_-Cancer-Care-Issues-Advice-From-Dr.pdf<Download

>Bevacizumab.zip<Download

>Biweekly-sunitinib-regimen-red-tox-retains-efficacy-in-mRCC-31-patients-_-UroToday.pdf<Download

>BrJourCancer-Active-Angiogenesis-in-mRCC-may-predict-for-sutent.doc<Download

>Cessation-of-vascular-endothelial-growth-factorANALYSIS.doc<Download

>cessation-of-VEGF-in-RCC-pts.pdf<Download

>Clinical-Outcomes-for-Patients-with-Metastatic-Renal-Cell-Carcinoma-Treated-with-Alternative-Sunitinib-Schedules.doc<Download

>clinical-outcomes-patientsmRCC-w-3lines-TT-Italian.pdf<Download

>Combination-Comparision-Studies.zip<Download

>Continued-targeted-therapy-after-CR.doc<Download

>CR-with-TKI-RCCJCO-2012-Albiges-JCO.2011.37.2516.pdf<Download

>Dr_Figlin_SOGUG.VEGF_Inhibition.11.11.11SLIDES-ONLY.pdf<Download

>Expansion-of-Targets-Inhibited-May-Highlight-More-Eff-Treatments-of-RCC.doc<Download

>Inlyta-ixitnib_files.zip<Download

>Integrating-Innovative-Therapeutic-Strategies-Into-the-Management-of-Renal-Cell-Carcinoma-Cancer-Network.pdf<Download

>Integrating-see-2077051-for-charts-Innovative-Therapies-into-Mgmt-of-RCC-Dutcher.pdf<Download

>JCO-CR-w-TKIs2012-Albiges-JCO.2011.37.2516.pdf<Download

>Managing-toxicities-optimal-dosing-of-targeted-drugs-in-adv-RCC-2009-CANA.pdf<Download

>Meyer-Fishman-RCC-overview-2013222.pdf<Download

>mTors-Ever-Temsiro.zip<Download

>Pazoponib.zip<Download

>re-mTOR-inhi-infect.pdf<Download

>Refining-2014Sunitinib-Immuneo-tx-OS-in-RCC.pdf<Download

>Resistance-in-TT-general.zip<Download

>Response-to-1st-Line-VEGFr-TT-OS-in-pts-w-mRCC-_-PracticeUpdate.pdf<Download

>sequential-therapies.pdf<Download

>Sorafenib.zip<Download

>Sunitinib-pazo-or-soraf-in-late-relapsing-RCC.doc<Download

>Sutent.zip<Download

>Systemic_Therapy.Advancing-Paradigms-Figlin-Posadas.pdf<Download

>TIVO.zip<Download

>TT-Basic-Issues-Updates<Download

>Targeted Therapies to Specific Immunotherapies<Download

Uncategorized:

>Evolving-Landscapre-of-RCC-Chourieri-zds00112000299.pdf<Download

>CTC-in-RCC-and-UC-patients.pdf<Download

>Craig-Venter-re-Genetic-Code-Human-Longevity.pdf<Download

>Conditional-Survival-Measures.pdf<Download

>cancer-and-anemia.doc<Download

>British-Journal-of-Cancer-Glasgow-Prognostic-Score-pts-w-nephs-ccRCC.pdf<Download

>Black-RCC-pts-vs-White-ESEARCH-REPORT.doc<Download

 >Adv-RCC-MD-Anderson-2012-From-OncoLog.doc<Download

>ACKC-Meeting-Dr.-Dutcher-Reports.doc<Download

>20100518_REDECTANEFinalDataPK_WILEX_IBA.pdf<Download

>First-line-for-RCC-Oncology-Clinical-Care-Options.pdf<Download

>guidelines-EURO-Renal-Cell-Carcinoma-2010.pdf<Download

>Han-from-Cedars-2012-re-update-esp-small-renal-masses.doc<Download

>Hutson-Choosing-First-Line-Therapy-for-Adv-RCC-ClinicalThought.doc<Download

>IKCC-ConfReport2012.pdf<Download

>Influence-of-tumour-micro-environment-heterogeneity-on-therapeutic-response-_-Nature-_-Nature-Publishing-Group.pdf<Download

>Jim-Watson_-DNA-revealed-the-causes-may-never-reveal-a-cure-Cancer-World.pdf<Download

>Johnson-UK-Basic-inc-scoring-RCC.pdf<Download

>KCA-10th-Symposium-Report.pdf<Download

>KCC-Journal-Targeted-usage-hess_v9n3.pdf<Download

>KCC-Survivorship-Survey-2011-Results-Summary-IKCC-March-14-2012.pdf<Download

>KCJourna-2012l.pdf<Download

>Kidney-Cancer-Journal-k_v9n1_opt.pdf<Download

>kidney-transparent-poster.pdf<Download

>Lucky-Me-Howard-Kanengiser.doc<Download

>Mayo-Clinic-re-experimental-drug-inhibits-growth-in-ccRCC-UroToday.pdf<Download

>Misdiagnosis-of-Renal-Cell-Carcinoma.doc<Download

>nihmicroenvironmental-regul-of-mets344205.pdf<Download

>Oxidants-antioxidants-and-the-current-incurability-of-metastatic-cancers.pdf<Download

>Prediction-of-Response-or-Survival-in-Kidney-Cancer.doc<Download

>Prognostic-Factors-and-Predictive-Models-in-Renal-Cell-Carcinoma_-A-Contemporary-Review.pdf<Download

>PubMedre-Vitespan-as-adjuvant.doc<Download

>Rationale-Relevance-of-Risk-in-ADV-RCC-Hutson_pfizer_WM.pdf<Download

>RCC-as-Chronic-Diseas-Escudier.pdf<Download

>RCC-journalclub_v9n3.pdf<Download

>RCC-MEDIFOCUS-Access-to-clinical-trial-info.pdf<Download

>RCC-Prevalence-Surprisingly-High-in-ADPKD-Patients-Renal-and-Urology-News.pdf<Download

>RCC-stats-Peg-rough.xls<Download

>WirhabenNierenkrebs.pdf<Download

>Brain-mets-and-SRS-treatment-Poteat.pdf<Download

>kidney-cancer-journal-2012.pdf<Download

>RCC-research-to-practice-Slides-mixed.pdf<Download

Leave a Reply

Your email address will not be published. Required fields are marked *